Skip to main content

Month: September 2025

Marimaca Copper – Update to A$80,000,000 Placement

Not for release to U.S. wire services or for distribution in the United States VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) — Marimaca Copper Corp. (TSX: MARI) (ASX: MC2) (“Marimaca” or the “Company”) announces that further to the previously announced best-efforts brokered placement in Australia and select other jurisdictions outside of Australia, except for Canada, the Company will issue an aggregate of 8,247,423 Chess Depositary Interests (“CDI”) at a price of A$9.70(1) per CDI for gross proceeds of approximately A$80,000,000 or approximately C$72,080,000 (the “Placement”). The net proceeds from the Placement will be used for detailed design and engineering and project related workstreams at the Marimaca Oxide Deposit (the “MOD”), exploration at the Pampa Medina Project and Marimaca sulphide target, and for general...

Continue reading

HUTCHMED Highlights Clinical Data to be Presented at the 2025 World Conference of Lung Cancer and the CSCO Annual Meeting 2025

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that new and updated data from several studies of compounds discovered by HUTCHMED will be presented at the 2025 World Conference on Lung Cancer (“WCLC”) taking place on September 6-9, 2025 in Barcelona, Spain, and the Chinese Society of Clinical Oncology (“CSCO”) Annual Meeting 2025, taking place on September 10-14, 2025 in Jinan, China. Updated analysis from savolitinib’s SACHI, SAVANNAH and a Phase IIIb confirmatory study in non-small cell lung cancer (“NSCLC”) patients will be presented at WCLC 2025. Savolitinib is an oral, potent and highly selective MET tyrosine kinase inhibitor (“TKI”) being jointly developed by AstraZeneca and HUTCHMED and commercialized by AstraZeneca....

Continue reading

Smithfield Foods Announces Pricing of Upsized Secondary Offering of Common Stock

SMITHFIELD, Va., Sept. 04, 2025 (GLOBE NEWSWIRE) — Smithfield Foods, Inc. (Nasdaq: SFD) (the “Company”), an American food company and an industry leader in value-added packaged meats and fresh pork, today announced the pricing of a secondary public offering of 19,531,698 shares of common stock of the Company sold by SFDS UK Holdings Limited, the principal shareholder of the Company, at a price to the public of $23.25 per share. In addition, the selling shareholder has granted the underwriters a 30-day option to purchase up to 2,929,754 additional shares of the Company’s common stock at the public offering price, less underwriting discounts and commissions. The Company is not selling any shares of common stock in the offering and will not receive any proceeds from the sale of the shares by the selling shareholder, including from...

Continue reading

Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology

SALT LAKE CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced The Lancet Oncology published a study highlighting the performance of Myriad’s molecular residual disease (MRD) test, Precise® MRD, in patients with oligometastatic clear-cell renal cell carcinoma (ccRCC). One of the goals of this study was to determine whether patients with oligometastatic ccRCC could benefit from incorporating ultrasensitive MRD testing into their care. The study demonstrated that circulating tumor DNA (ctDNA) levels were associated with patients’ response to metastasis-directed radiation therapy (MDT). Precise MRD was able to detect ctDNA levels in patients with very low tumor burden. This may allow patients who are candidates for metastasis-directed...

Continue reading

Oportun Awards College Scholarships to Winners of 2025 Oportun Scholarship Program

Winners hail from California and Texas SAN CARLOS, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) — Oportun (Nasdaq: OPRT), a mission-driven financial services company and provider of responsible, affordable financial products, has announced the 25 recipients of its 2025 Oportun Scholarship Program. The program honors students who demonstrate a strong commitment to their education and communities, with many overcoming significant financial barriers to reach their goals. In addition to their scholarship award, each recipient will receive four years of complimentary access to Oportun’s Set and Save™ app, a tool designed to help members build consistent savings habits. To further support their financial journey, Oportun will also match their savings up to $500. In 2025, Oportun awarded scholarships to students from California and...

Continue reading

Visa Marks 28 Years with TIFF and Debuts Exclusive New Experiences for Cardholders

From premium lounges to local programs, Visa opens the doors to TIFF for cardholders and the communityPhoto Credit: Ania Potyrala/For The Canadian Press Images A Media Snippet accompanying this announcement is available by clicking on this link. TORONTO, Sept. 04, 2025 (GLOBE NEWSWIRE) — Visa Canada proudly returns for its 28th consecutive year as a sponsor of the Toronto International Film Festival (TIFF). This year’s sponsorship is a milestone as TIFF celebrates its 50th edition—a landmark moment for cinema, artists, and Canada’s film industry. “Visa is proud to support TIFF’s mission to change the way people see the world by expanding access to a festival that celebrates the best in arts, culture, and community,” said Heather Nobes, Vice President of Marketing, Visa Canada. “For nearly three decades, Visa has helped to open...

Continue reading

Prime Drink Group Terminates Rights Offering and Announces Private Placement

MONTREAL, Sept. 04, 2025 (GLOBE NEWSWIRE) — Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) announces that it has terminated its previously disclosed rights offering and that it is proceeding with a non-brokered private placement offering of units of the Company (the “Units”) to raise maximum gross proceeds of $5,000,000 (the “Unit Offering”). Each Unit will be offered at a price of $5,000 per Unit and is comprised of 62,500 common shares in the capital of the Company (the “Common Shares”) and 62,500 transferable share purchase warrants (the “Warrants”), resulting in the aggregate issuance of a maximum of 62,500,000 Common Shares issued at a deemed price per share of $0.08 and a maximum of 62,500,000 Warrants. Each Warrant entitles the holder to purchase a Common Share at a price of $0.085 per Common Share for a...

Continue reading

Bombardier Announces Pricing of US$250 million of Additional 6.75% Senior Notes due 2033

MONTRÉAL, Sept. 04, 2025 (GLOBE NEWSWIRE) — Bombardier Inc. (“Bombardier”) today announced that it has successfully priced its offering of US$250 million aggregate principal amount of Senior Notes due 2033 (the “Additional Notes”). The Additional Notes will be a further issuance of, and form a single series with, the existing $500 million aggregate principal amount of its 6.750% Senior Notes due 2033 that were originally issued on May 29, 2025. The Additional Notes will carry a coupon of 6.750% per annum and will be sold at a price of 103.500% plus accrued interest from, and including, May 29, 2025 to, but excluding, the issue date of the Additional Notes. The issuance of the Additional Notes is expected to close on or about September 18, 2025, subject to customary closing conditions. Bombardier intends to use the proceeds of the...

Continue reading

Bombardier Announces Conditional Notice of Redemption for All of its 7.125% Senior Notes due 2026 and Conditional Notice of Partial Redemption for US$83,711,000 of its 7.875% Senior Notes due 2027

MONTREAL, Sept. 04, 2025 (GLOBE NEWSWIRE) — Bombardier Inc. (“Bombardier”) today announced that it has issued a conditional notice of redemption for all of its outstanding 7.125% Senior Notes due 2026 (the “2026 Notes”), and a conditional notice of partial redemption for US$83,711,000 aggregate principal amount of its outstanding 7.875% Senior Notes due 2027 (the “2027 Notes” and, together with the 2026 Notes, the “Redemption Notes”). As set forth in the conditional notice of redemption issued today in respect of the 2026 Notes, the redemption date is October 4, 2025, and the redemption price for the 2026 Notes is 100% of the principal amount redeemed, plus accrued and unpaid interest. As set forth in the conditional notice of partial redemption issued today in respect of the 2027 Notes, the redemption date is October 4, 2025,...

Continue reading

Faraday Future Announces its Annual 919 Futurist Day & Shareholders’ Day on September 19

Faraday Future Announces its Annual 919 Futurist Day & Shareholders’ Day on September 19Faraday Future today announced that it will host its 919 Futurist Day & Shareholders’ Day on September 19, 2025, from 3:30 PM – 6:00 PM PDT at the Company’s global headquarters in Los Angeles.LOS ANGELES, Sept. 04, 2025 (GLOBE NEWSWIRE) — Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or “Company”), a California-based global shared intelligent electric mobility ecosystem company, today announced that it will host its 919 Futurist Day & Shareholders’ Day on September 19, 2025, from 3:30 PM – 6:00 PM PDT at the Company’s global headquarters in Los Angeles.  9/19 Event Highlights Preview:  EAI FlywheelExclusive immersive experience of FX Super One’s unveiled product features. In-depth...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.